Search This Blog

Thursday, February 28, 2019

Acceleron treatment of Charcot-Marie-Tooth disease gets FDA orphan tag

In a post on the FDA’s website, Acceleron’s treatment of Charcot-Marie-Tooth disease, efmitermant alfa, received FDA orphan designation.
https://thefly.com/landingPageNews.php?id=2872741
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)